Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?

Audiology and Neurotology

Volumn 14, Issue 3, 2009, Pages 139-145

  Ballesteros, F ^a   Alobid, I ^a   Tassies, D ^a   Reverter, J C ^a   Scharf, R E ^b   Guilemany, J M ^a   Bernal Sprekelsen, M ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cardiovascular risk factors; DNA polymorphisms; Factor V Leiden; Hypercholesterolemia; Prothrombin; Sudden hearing loss; Sudden sensorineural hearing loss; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BUFLOMEDIL; METHYLPREDNISOLONE; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SCHOOL CHILD; STROKE; SUDDEN DEAFNESS; THROMBOPHILIA; VASCULAR DISEASE;

AGED; CARDIOVASCULAR DISEASES; FEMALE; GENETIC VARIATION; GENOTYPE; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HETEROZYGOTE DETECTION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 63449093440     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000171475     Document Type: Article

References (42)

1. Alford BR, Shaver EF, Rosenberg JJ, Guildford FR: Physiologic and histopathologic effects of microembolization of the internal auditory artery. Ann Otol Rhinol Laryngol 1965; 74: 728-748.
2. Billings PB, Keithley EM, Harris JP: Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sear with heat shock protein 70. Ann Otol Rhinol Laryngol 1995; 104: 181-188.
3. Boom R, Sol CJ, Salimans MM, Jansen CL, Wherteim-van Dillen PM, van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.
4. Byl FM: Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984; 94: 647-661.
5. Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, Censuales S, Pignataro L: Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 2007; 117: 547-551.
6. Dahlback B, Carlsson M, Svenson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nat Acad Sci USA 1993; 90: 1004-1008.
7. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr: Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-765.
8. de Kleyn A: Sudden complete or partial loss of function in the octavus system in apparently normal persons. Acta Otolaryngol 1944; 32: 407-425.
9. Dullaart RP, Hoogenberg K, Dikkeschei BD, Van Tol A: Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994; 14: 1581-1585.
10. Foger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR: Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism 1994; 43: 633-639.
11. Goodhill W: The 'idiopathic group' and the 'labyrinthine window rupture group' approaches to sudden sensorineural hearing loss; in Snow JB Jr (ed): Controversy in Otolaryngology. Philadelphia, Saunders, 1980, pp 12-20.
12. Görur K, Tuncer U, Eskandari G, Özkan C, Uönal M, Özsahinoglu C: The role of factor V Leiden and phrothrombin G20210A mutations in sudden sensorineural hearing loss. Otol Neurotol 2005; 26: 599-601.
13. Grgic M, Petric V, Grgic MP, Demarin V, Pegan B: Doppler ultrasonography of the vertebrobasilar circulation in patients with sudden sensorineural hearing loss. J Otolaryngol 2005; 34: 51-59.
14. Gussen R: Sudden hearing loss associated with vascular origins: a temporal bone study. Ann Otol Rhinol Laryngol 1976; 85: 94-100.
15. Harris JP: Immunology of the inner ear: response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 1983; 91: 18-23.
16. Igarashi M, Alford BR, Konishi S, Shaver EF, Guilford FR: Functional and histopathological correlates after microembolization of the peripheral labyrinthine artery in the dog. Laryngoscope 1969; 79: 602-623.
17. Jaffe BF: Sudden deafness a local manifestation of systemic disorders: fat emboli, hypercoagulation, and infection. Laryngoscope 1970; 80: 788-801.
18. Jaffe BF: Hypercoagulation and other causes of sudden hearing loss. Otolaryngol Clin North Am 1975; 8: 395-403.
19. Jaffe BF: Viral causes of sudden inner ear deafness. Otolaryngol Clin North Am 1978; 10: 63-69.
20. Jaffe BF, Maasab HF: Sudden deafness associated with adenovirus infection. N Engl J Med 1967; 276: 1406-1409.
21. Jenkins HA, Pollack AM, Fisch U: Polyarteritis nodosa as a cause of sudden deafness. Am J Otolaryngol 1981; 2: 99-107.
22. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J: Modified test for activated protein X resistance. Lancet 1994; 344: 1162-1163.
23. Lipkin AF, Jenkins HA, Coker NJ: Migraine and sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1987; 113: 325-326.
24. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585-589.
25. Mercier E, Quere I, Chabert R, Lallemant JG, Daures JP, Berlan J, Gris JP: The 20210A allele of the prothrombin gene is an independent risk factor for perception deafness in patients with venous thromboembolic antecedents (letter). Blood 1999; 93: 3150-3152.
26. Muñoz-Rodriguez FJ, Reverter JC, Font J, Tassies D, Espinosa G, Cervera R, et al: Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus. Lupus 2002; 11: 730-735.
27. Patscheke JH, Arndt J, Dietz K, Zenner HP, Reuner KH: The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients. Thromb Haemost 2001; 86: 1118-1119.
28. Perlman HB, Kumura R: Experimental obstruction of the venous drainage and arterial supply of the inner ear. Ann Otol Rhinol Laryngol 1957; 66: 537-546.
29. Pohle K, Ropers D, Geitner P, Regenfus M, Daniel WG, Achenbach S: Analysis of coronary calcifications versus Framingham and PROCAM risk assessment in patients with a first myocardial infarction. Int J Cardiol 2006; 110: 231-236.
30. Poort SR, Rosendaal FR, Reitsma PH, Berina RM: A common genetic variation in the 3- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
31. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH: Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-708.
32. Rudack C, Langer C, Junker R: Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res 2004; 191: 41-48.
33. Rudack C, Langer C, Stoll W, Rust S, Walter M: Vascular risk factors in sudden hearing loss. Thromb Haemost 2006; 95: 454-461.
34. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G: Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23.
35. Scherer EQ, Arnold W, Wangemann P: Pharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss. BMC Ear Nose Throat Disord 2005; 5: 10.
36. Suckfuöll M; Hearing Loss Study Group: Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002; 360: 1811-1817.
37. Thein SL, Walance RB: The use of synthetic oligonucleotides as specific hybridization probes in the diagnosis of genetic disorders; in Davis DE (ed): Human Genetic Diseases: A Practical Approach. Oxford, IRL Press, 1986, pp 33-50.
38. Veldman JE, Roord JJ, O'Connor AF, Shea JJ: Autoimmunity and inner ear disorders: an immune-complex mediated sensorineural hearing loss. Laryngoscope 1984; 94: 501-507.
39. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-2033.
40. Yang Q, Kathiresan S, Lin JP, Tofler GH, O'Donnell CJ: Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet 2007; 8(suppl 1):S12.
41. Yoo TJ, Tomoda K, Stuart JM, Cremer MA, Townes AS, Kang AH: Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol 1983; 92: 267-271.
42. Yoo TJ, Tomoda K, Stuart JM, Cremer MA, Townes AS, Kang AH: Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol 1983; 92: 267-271.